<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02972996</url>
  </required_header>
  <id_info>
    <org_study_id>HNS 01</org_study_id>
    <nct_id>NCT02972996</nct_id>
  </id_info>
  <brief_title>Blueberry Consumption and Type 2 Diabetes</brief_title>
  <official_title>Effects of Blueberry Consumption on Cardiometabolic Parameters in Men With Type 2 Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albany Research Institute, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Albany Research Institute, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lifestyle strategies that include dietary modification, such as consumption of a plant-based
      diet, are well recognized in disease prevention and may improve type 2 diabetes. Various
      components of a plant-based diet may contribute to its beneficial health effects, but there
      has been keen interest in the possibility that plant polyphenols may have a role. Blueberries
      are dietary sources of polyphenols, specifically anthocyanins. To date there are few human
      clinical trials evaluating the beneficial health effects of blueberries in populations with
      type 2 diabetes. The objective of the study is to determine if freeze-dried blueberries
      compared to a blueberry placebo will improve cardiometabolic parameters in men with type 2
      diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">January 19, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Type2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Blueberry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blueberry</intervention_name>
    <description>22 g freeze-dried whole blueberry powder</description>
    <arm_group_label>Blueberry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>22 g placebo blueberry powder</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  Ages 45 to 75 years at beginning of study

          -  BMI &gt;25 kg/m2

          -  HbA1C &gt; 6.5 and &lt; 9

          -  Medical diagnosis of type 2 diabetes for at least 6 months

        Exclusion Criteria:

          -  Use of insulin

          -  Presence of chronic kidney disease (GFR &lt; 45 mL/min), liver cirrhosis,
             gastrointestinal disease, pancreatic disease, or malabsorption syndromes

          -  Weight loss of &gt;10% of body weight over the last 6 months; routine participation in
             heavy exercise

          -  Heavy smokers (&gt;20 cigarettes per day)

          -  Unable or unwilling to give informed consent or communicate with study staff

          -  Other medical, psychiatric, or behavioral factors that in the judgment of the
             Principal Investigators may interfere with study participation or the ability to
             follow the intervention protocol

          -  Allergies to blueberries or blueberry products
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaret M. Wilson, MS, RD, CDE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stratton V.A. Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stratton V.A. Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>November 22, 2016</study_first_submitted>
  <study_first_submitted_qc>November 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2016</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>October 1, 2019</submitted>
    <submission_canceled>October 4, 2019</submission_canceled>
    <submitted>October 8, 2019</submitted>
    <returned>October 29, 2019</returned>
    <submitted>January 21, 2020</submitted>
    <returned>January 29, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

